August 23, 2011 — The Center of Innovation for Nanobiotechnology (COIN), a non-profit commercialization center dedicated to the development and growth of nanobiotechnology-related industries, appointed Griffith Kundahl its executive director.

Kundahl will attend the Commercialization of Micro-Nano Systems (COMS) event, August 28-31 in Greensboro, NC, which COIN co-hosts with the Micro and Nanotechnology Commercialization Education Foundation.

Commercialization of nanobiotechnologies, locally, nationally and internationally will be Kundahl’s main charter, explained Roger Cubicciotti, Chairman of the COIN Board of Directors and President of Nanomedica Inc. COIN "strategically aligns across the value chain with the investment community, universities, researchers, and government labs and regulatory agencies," added Rob Burns, SVP of Lux Research.

Kundahl has an extensive background in emerging technology law, public policy, communications, and industry relations. He formerly served as General Counsel of the NanoBusiness Alliance, the national trade association for the nanotechnology community, as well as Executive Chairman of the Colorado Nanotechnology Alliance. He was also the Vice President for Convergence (nano, bio and IT) in the Life Sciences section of Ogilvy Public Relations Worldwide. Most recently, Kundahl served at the University of Denver School of Engineering and Computer Science as Director of Global Programs. Kundahl holds a bachelor’s degree from The University of Pennsylvania, a master’s degree from The University of Alabama and a law degree from The University of Denver.

COIN is a non-profit, virtual center of innovation serving as a catalyst for commercialization in the healthcare, agriculture, water, and energy sectors. Visit COIN’s website at www.nanobiotech.org.